NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity

Related articles

1. Targeting tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockade

   This article has 10 authors:

   1. Sapana P. Bansod
   2. Timothy Hung-Po Chen
   3. Vikas K. Somani
   4. Lin Li
   5. Suneeta Modekurty
   6. Brett L. Knolhoff
   7. Ryan C. Fields
   8. Marianna B. Ruzinova
   9. David G. DeNardo
   10. Kian-Huat Lim

2. A post-transcriptional regulatory checkpoint controls the response of tumor-infiltrating cytotoxic CD4 ⁺ T cells to immunotherapy

   This article has 17 authors:

   1. María Vila de Mucha
   2. Julia Hłond
   3. Cristobal Costoya
   4. Ching-In Lau
   5. Anna Śledzińska
   6. Imran Uddin
   7. Mariela Navarrete
   8. Mansi Shah
   9. Gerasimos Mastrokalos
   10. Despoina Karagianni
   11. Sarah E. Bell
   12. Callum Nattress
   13. Gordon Beattie
   14. Christopher J. Tape
   15. Martin Turner
   16. Sergio A. Quezada
   17. Richard G. Jenner

3. Transcriptional reprogramming of tumor-infiltrating T cells during PD-1 blockade revealed through gene regulatory network and trajectory inference in squamous cell carcinoma

   This article has 4 authors:

   1. Roger Casals-Franch
   2. Jordi Villà-Freixa
   3. Lara Nonell
   4. Adrián López García de Lomana